FDA, Novavax and influenza vaccine
The right time is now to get your flu vaccine, says the FDA
Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug Administration says.
FDA puts Novavax's phase 3 plan for pair of vaccine programs on hold over nerve disease case
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu programs on hold in response to a case of nerve disease from a former parti | The phase 2 trial wrapped up in July 2023,
Novavax shares sink as US FDA puts trial of combo COVID-flu vaccine on hold
Shares in Novavax (NASDAQ:NVAX) slumped in premarket US trading on Wednesday after the US Food and Drug Administration placed a trial of its experimental COVID-19 and influenza vaccine combination on hold.
Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines
Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and standalone flu inoculation, sending shares down sharply.
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.
Novavax Shares Plummet 20% Following FDA Hold on Covid-Flu Vaccine Application
Novavax announced Wednesday that the Food and Drug Administration (FDA) has placed a clinical hold on its application for a combination of Covid-19 and influenza vaccines, as well as its stand-alone flu vaccine.
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
Shares of Novavax NVAX lost nearly 20% on Wednesday after the company announced that the FDA has placed a clinical hold on its experimental COVID-19-Influenza Combination (“CIC”) and stand-alone influenza vaccine candidates.
FDA halts Novavax's vaccine trials after safety scare
The U.S. Food and Drug Administration (FDA) has suspended Novavax's experimental combined COVID-19 and flu vaccine clinical trials. This decision followed reports of a participant's symptoms of nervous system damage,
Novavax stock plunges as FDA puts clinical hold on COVID-flu combo vaccine
Shares of Novavax (NASDAQ:NVAX) fell roughly 30% Wednesday morning after the U.S. FDA put a clinical hold on the new drug application of its COVID-19 and influenza combination vaccine and standalone influenza vaccine candidates,
RSV, vaccine
The Chronicle2d
Duke Human Vaccine Institute to develop avian flu vaccine protecting against variants, provide long-lasting immunity
The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...
2minutemedicine.com4d
AstraZeneca’s FluMist first and only self-administered flu vaccine
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
McKnight's Long-Term Care News1d
Vaccine about 80 percent effective against severe RSV, hospitalization and death
The respiratory syncytial virus (RSV) vaccines were about 80% effective in older adults during the 2023-24 respiratory disease season, which was the first season after the shot was approved in the US, ...
Portfolio3d
Free influenza vaccine to be available in Hungary by end-October
The Respiratory Surveillance Service has begun operating in Hungary as a first step in preparing for the flu season.
CT DPH Confirms Season's First Influenza Deaths
An infant, and a 90+ year-old adult, were the first Connecticut residents to die from the flu in the 2024-25 season.
FDA Updates Sanofi's FLUBLOK Vaccine Label With New Safety Data For Pregnant Individuals
Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...